April 4, 2007 Presentation: PGx and Algorithms for Warfarin Therapy
Mark W. Linder, PhD, DABCC, FACB, is Associate Professor of the Department of Pathology and Laboratory Medicine. He serves as the Assistant Director of Clinical Chemistry and Toxicology at the University of Louisville Hospital and as Associate Director of the Pharmacogenetics Diagnostic Laboratory within the Department of Pathology and Laboratory Medicine. Dr. Linder received his PhD degree at the University of Louisville in Biochemistry (1992) and completed postdoctoral fellowships in Clinical Chemistry and Clinical Toxicology the University of Louisville. He joined the faculty in the Department of Pathology in 1999. He is a Fellow of the National Academy of Clinical Biochemistry and serves on a number of committees for the American Association for Clinical Chemistry. His scientific interests include mechanisms for regulation of drug metabolism and transitioning the science of both pharmacogenetics (PGx) and proteomics into clinical laboratory practice.
Question & Answer